Therapy de‐escalation in paediatric patients with inflammatory bowel disease in remission: Data analysis from the CEDATA registry
De-escalation is more likely successful in patients with CD, and de-escalating combination therapy to monotherapy with a TNF-alpha-inhibitor is more advantageous.
Authors
- Jan de Laffolie (ORCID: https://orcid.org/0000-0003-1023-7442)
- Sila Cekin (ORCID: https://orcid.org/0009-0005-9243-2007)
- Christoph Huenseler
- Serdar Cantez (ORCID: https://orcid.org/0000-0002-0150-912X)
- Ilse Broekaert (ORCID: https://orcid.org/0000-0002-7802-3064)
Institutions
- University of Cologne (DE)
- Universitätsklinikum Gießen und Marburg (DE)
- Giessen School of Theology (DE)
- University Hospital Cologne (DE)
Publication Details
- Journal
- Journal of Pediatric Gastroenterology and Nutrition
- Published
- 2025-12-12
- DOI
- https://doi.org/10.1002/jpn3.70297
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Sanofi
- Dr. Falk Pharma